Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 181 ~ 200 of 25905, Page 10 of 1296
181. Japanese Red Cross Society Selects Abbott Technology to Screen Country''s Blood and Plasma Supply
LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN
01/17/2019 Abbott
182. FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
01/16/2019 U.S. FOOD & DRUG ADMINISTRATION
183. Abbott To Acquire Cephea Valve Technologies, Inc.
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
01/16/2019 Abbott
184. Statement from FDA Commissioner, Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
01/15/2019 U.S. FOOD & DRUG ADMINISTRATION
185. Medtronic Launches Mobile App That Communicates Directly with World''s First Smartphone-Connected Pacemakers
MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics
01/15/2019 Medtronic
186. Personalized Treatment Benefits Kidney Cancer Patients
Patients who have risk factors for worsening kidney disease may benefit from personalized treatment plans / Researchers constructed a simulation model to assess the impact of different treatment approaches in patients with small renal tumors. /
01/15/2019 Radiological Society of North America
187. AAOS Praises Introduction of Hospital Competition Act
01/15/2019 American Academy of Orthopaedic Surgeons
188. Merck’s KEYTRUDA® (pembrolizumab) Reduced Risk of Death by 31 Percent Compared to Chemotherapy in Previously Treated Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1 (CPS ≥10)
Results from Phase 3 KEYNOTE-181 Trial to be Presented at 2019 Gastrointestinal Cancers Symposium (ASCO GI)
01/14/2019 MERCK
189. FDA Approves World''s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)
First and only minimally invasive, transcatheter treatment specifically approved for premature babies with a patent ductus, a life-threatening opening in their heart
01/14/2019 Abbott
190. Abbott and Malaria No More Work Together to End Malaria in Odisha, India
Abbott to supply rapid diagnostic tests critical for malaria detection and surveillance, technical expertise and funding support / Initiative focuses on Odisha, the state with the highest burden of malaria in India
01/11/2019 Abbott
191. Online ACS Community Helps Researchers Collaborate
TheoryLab® is an online community exclusively for scientists and clinical professionals who have a current or previous relationship with the American Cancer Society. The goal is to provide a place for some of the brightest minds in cancer research to work together to accelerate our progress toward a world without cancer.
01/10/2019 American Cancer Society
192. Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
01/08/2019 American Cancer Society
193. “Zero polio transmission and health for all”, WHO Director-General gives new year’s wish to the people of Afghanistan and Pakistan
01/08/2019 WHO
194. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
01/07/2019 U.S. FOOD & DRUG ADMINISTRATION
195. Take a Moment With Meditation
Our busy lives can leave us frazzled and stressed. Studies show taking a mental break with meditation can quiet the mind and improve health. We’ll walk you through the basics.
01/07/2019 American Cancer Society
196. Cutting Calories With Portion Control
Portion sizes have increased over the years, making it easier for Americans to overeat. Read about creative ways to cut back on calories by eating smaller portions of meals and snacks.
01/04/2019 American Cancer Society
197. New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health
IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance
01/03/2019 Medtronic
198. Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes
MK-3655 (formerly known as NGM313) is a proprietary, investigational agonistic antibody that selectively activates the β-Klotho/FGFR1c receptor complex.
01/03/2019 MERCK
199. Merck’s KEYTRUDA® (pembrolizumab) Receives Five New Approvals in Japan, Including in Advanced Non-Small Cell Lung Cancer (NSCLC), as Adjuvant Therapy for Melanoma, and in Advanced Microsatellite Instability-High (MSI-H) Tumors
KEYTRUDA is the First Anti-PD-1 Approved in Japan for the First-Line Treatment of Advanced NSCLC as Both Monotherapy and in Combination with Chemotherapy / With New MSI-H Indication, KEYTRUDA is the First Cancer Therapy Approved in Japan for Use Based on a Biomarker, Regardless of Tumor Type
01/03/2019 MERCK
200. WHO Director-General concludes New Year visit to Ebola-affected areas in the Democratic Republic of the Congo
01/03/2019 WHO
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱